A scalable and high yielding SARS-CoV-2 spike protein receptor binding domain production process

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike protein is of interest for the development of vaccines and therapeutics against COVID-19. Vaccines are designed to raise an immune response against the spike protein. Other therapies attempt to block the interaction of the spike...

Descripción completa

Detalles Bibliográficos
Autores principales: Riguero, Valeria, Delmar, Jared, Dippel, Andrew, McTamney, Patrick, Luo, Ethan, Martinez, Antonio, Ren, Kuishu, van Dyk, Nydia, O'Connor, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890279/
https://www.ncbi.nlm.nih.gov/pubmed/36736512
http://dx.doi.org/10.1016/j.pep.2023.106241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890279/
https://www.ncbi.nlm.nih.gov/pubmed/36736512
http://dx.doi.org/10.1016/j.pep.2023.106241

Ejemplares similares